Sussex Research Laboratories Inc. will be closed from December 24, 2021 (Christmas Eve) to January 3rd, 2022. Thank you to our wonderful customers for your business. Happy Holidays & All the Best in 2022!

Tf Antigen: Fmoc-Ser(Galβ(1-3)GalNAc)-OH (Peracetate)

Tf Antigen: Fmoc-Ser(Galβ(1-3)GalNAc)-OH (Peracetate) molecular structure


SKUPack SizeAvailabilityPriceQuantity
GA121010-25MG25mgIn StockUS$700.00
GA121010-100MG100mgIn StockUS$1,850.00
GA121010-250MG250mgIn StockUS$3,750.00
GA121010-500MG500mgIn StockUS$6,000.00

Product Details

Name Tf Antigen: Fmoc-Ser(Galβ(1-3)GalNAc)-OH (Peracetate)
Product No.GA121010
Synonym(s) Tf Epitope (Serine); T Antigen (Serine,Fmoc, Peracetylated); Thomsen–Friedenreich Antigen; Core 1 Glycan (Serine); Fmoc-L-Ser(Galβ(1-3)GalNAc)-OH (Peracetate); Fmoc-Ser[β-Gal(Ac)₄-(1-3)-α-GalNAc(Ac)₂]-OH; O-{2-N-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-4,6-di-O-acetyl-2-deoxy-α-D-galactopyranosyl}-N α-(fluoren-9-yl-methoxycarbonyl)-L-Serine
CategoryGlycoamino AcidsSerine
CAS No.125760-30-7
Molecular Weight944.88
Availability in BulkYes
Purity>95% (HPLC)
DescriptionTumor-Associated Carbohydrate Antigen (TACA). TF is a truncated O-glycosylated core determinant (Core 1) with structure: Galβ1-3GalNAcα-O-Ser/Thr. In normal Mamalian cells, the TF determinant is masked by larger glycan residues. Once unmasked, TF serves as an important recognition element, mediating several cell-cell interactions. As such, TF is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered TF a potential target for cancer immunotherapy.
CommentsN-Acetyl-D-Galactosamine; O-Link; Disaccharide; Serine; Blocked; Amino Acid; Ac
ReferencesF.J. Irazoqui et al., Immunology and Cell Biology 2005, 83, 405–415
Datasheet(s)GA121010_COA.pdf (84.147 KB)
‹ Back to Catalogue